Shanshan Lu

5.1k total citations
184 papers, 3.5k citations indexed

About

Shanshan Lu is a scholar working on Molecular Biology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shanshan Lu has authored 184 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 42 papers in Epidemiology and 40 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shanshan Lu's work include Acute Ischemic Stroke Management (32 papers), Cerebrovascular and Carotid Artery Diseases (23 papers) and Venous Thromboembolism Diagnosis and Management (13 papers). Shanshan Lu is often cited by papers focused on Acute Ischemic Stroke Management (32 papers), Cerebrovascular and Carotid Artery Diseases (23 papers) and Venous Thromboembolism Diagnosis and Management (13 papers). Shanshan Lu collaborates with scholars based in China, United States and Norway. Shanshan Lu's co-authors include Zhi‐Qiang Xiao, Hai‐Bin Shi, Hong Yi, Ta Xiao, Xiao‐Quan Xu, Wei Gu, Xunning Hong, Baochang Cai, Qing‐Quan Zu and Hongmei Yi and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Nature Communications.

In The Last Decade

Shanshan Lu

177 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shanshan Lu China 33 1.2k 478 461 381 327 184 3.5k
Ren-Shyan Liu Taiwan 31 905 0.7× 431 0.9× 220 0.5× 365 1.0× 513 1.6× 160 2.8k
Kathrin Geiger Germany 37 2.1k 1.7× 693 1.4× 680 1.5× 316 0.8× 315 1.0× 137 4.9k
Jing Xu China 34 1.7k 1.4× 373 0.8× 346 0.8× 267 0.7× 146 0.4× 152 4.0k
Ariel Miller Israel 44 1.3k 1.1× 465 1.0× 534 1.2× 174 0.5× 348 1.1× 140 7.8k
Shuang Wu China 32 963 0.8× 336 0.7× 177 0.4× 503 1.3× 376 1.1× 217 3.5k
Jason Chen United States 32 1.5k 1.2× 456 1.0× 369 0.8× 621 1.6× 184 0.6× 130 4.5k
Eun Young Song South Korea 34 1.0k 0.8× 286 0.6× 548 1.2× 220 0.6× 110 0.3× 211 3.8k
Jia Li China 36 2.1k 1.7× 453 0.9× 283 0.6× 210 0.6× 147 0.4× 219 4.6k
Li Ni China 35 1.4k 1.2× 307 0.6× 324 0.7× 167 0.4× 285 0.9× 137 3.7k
Lian Li United States 32 720 0.6× 226 0.5× 748 1.6× 289 0.8× 627 1.9× 126 3.5k

Countries citing papers authored by Shanshan Lu

Since Specialization
Citations

This map shows the geographic impact of Shanshan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanshan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanshan Lu more than expected).

Fields of papers citing papers by Shanshan Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shanshan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanshan Lu. The network helps show where Shanshan Lu may publish in the future.

Co-authorship network of co-authors of Shanshan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Shanshan Lu. A scholar is included among the top collaborators of Shanshan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shanshan Lu. Shanshan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chu, M. C., Shimeng Zhang, Jinlong Gong, et al.. (2025). Telemedicine-based integrated management of atrial fibrillation in village clinics: a cluster randomized trial. Nature Medicine. 31(4). 1276–1285. 9 indexed citations
2.
Xu, Wei, Baokun Zhang, Shanshan Lu, et al.. (2024). Clinical features and mechanisms of neck myoclonus in narcolepsy. Sleep Medicine. 123. 22–28.
4.
Zhang, Nan, Shanshan Lu, Jing Sheng, et al.. (2024). A naphthalimide-based fluorescent platform for endoplasmic reticulum targeted imaging. Chemical Communications. 60(65). 8565–8568. 5 indexed citations
5.
Cao, Xiaocheng, Xueli Mao, Shanshan Lu, et al.. (2024). A PD-L1-Targeted Probe Cy5.5-A11 for In Vivo Imaging of Multiple Tumors. ACS Omega. 9(43). 43826–43833. 1 indexed citations
7.
Yin, Hang, Shanshan Lu, Chenyu Wang, et al.. (2023). Prognostic value of multiphase CT angiography: estimated infarct core volume in the patients with acute ischaemic stroke after mechanical thrombectomy. Clinical Radiology. 78(11). e815–e822. 4 indexed citations
8.
Tang, Hao, Qizhen Li, Huan Xu, et al.. (2023). Anti‐Coronaviral Nanocluster Restrain Infections of SARS‐CoV‐2 and Associated Mutants through Virucidal Inhibition and 3CL Protease Inactivation. Advanced Science. 10(13). e2207098–e2207098. 4 indexed citations
9.
Tang, Tianyu, Jiaying Zhou, Jiulou Zhang, et al.. (2022). ISP-Net: Fusing features to predict ischemic stroke infarct core on CT perfusion maps. Computer Methods and Programs in Biomedicine. 215. 106630–106630. 10 indexed citations
10.
Lu, Shanshan, Yuezhou Cao, Xiao‐Quan Xu, et al.. (2022). ASPECTS-based net water uptake predicts poor reperfusion and poor clinical outcomes in patients with ischemic stroke. European Radiology. 32(10). 7026–7035. 10 indexed citations
12.
Lu, Shanshan, Huahao Fan, Zeliang Chen, et al.. (2021). The Coxiella burnetii QpH1 Plasmid Is a Virulence Factor for Colonizing Bone Marrow-Derived Murine Macrophages. Journal of Bacteriology. 203(9). 11 indexed citations
13.
Lu, Shanshan, Xiao Zhang, Yu Zhou, & Shilong Sun. (2021). MOEA/D based UAV swarm deployment for wireless coverage. 100–106. 6 indexed citations
14.
Zhang, Lingling, Xiangjun Liu, Shanshan Lu, et al.. (2020). Thiazole Orange Styryl Derivatives as Fluorescent Probes for G-Quadruplex DNA. ACS Applied Bio Materials. 3(5). 2643–2650. 34 indexed citations
15.
Liu, Zhenhong, Pengwen Wang, Shanshan Lu, et al.. (2020). Liquiritin, a novel inhibitor of TRPV1 and TRPA1, protects against LPS-induced acute lung injury. Cell Calcium. 88. 102198–102198. 60 indexed citations
16.
Liu, Jing, Xiangjun Liu, Shanshan Lu, et al.. (2020). Ratiometric detection and imaging of hydrogen sulfide in mitochondria based on a cyanine/naphthalimide hybrid fluorescent probe. The Analyst. 145(20). 6549–6555. 29 indexed citations
17.
Feng, Juan, Shanshan Lu, Ta Xiao, et al.. (2020). ANXA1 Binds and Stabilizes EphA2 to Promote Nasopharyngeal Carcinoma Growth and Metastasis. Cancer Research. 80(20). 4386–4398. 38 indexed citations
18.
Wang, Yan, Nan Zhang, Shanshan Lu, et al.. (2019). Dual-Monitoring Glycosylation and Local pH in Live Cells by Metabolic Oligosaccharide Engineering with a Ratiometric Fluorescent Tag. Analytical Chemistry. 91(21). 13720–13728. 8 indexed citations
19.
Wang, Xinshi, Xin Tian, Yong Yang, et al.. (2017). POSH participates in epileptogenesis by increasing the surface expression of the NMDA receptor: a promising therapeutic target for epilepsy. Expert Opinion on Therapeutic Targets. 21(12). 1083–1094. 7 indexed citations
20.
Qu, Jia‐Quan, Hongmei Yi, Ye Xu, et al.. (2015). MiRNA-203 Reduces Nasopharyngeal Carcinoma Radioresistance by Targeting IL8/AKT Signaling. Molecular Cancer Therapeutics. 14(11). 2653–2664. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026